Schneider Electric automation and control products and solutions cover the breadth of the industrial, infrastructure and building sectors -- from programmable relays to motion controllers and interface modules, for applications from simple machines to complex process systems.
Thank you for subscribing to updates from Schneider Electric. You will receive your welcome email soon describing the program and what to expect in the upcoming weeks.
Imagine that a German widget manufacturer and an American customer are negotiating an order. "This corroboration requirement for testimony by an interested party is based on the sometimes unreliable nature of oral testimony, due to the forgetfulness of witnesses, their liability to mistakes, their proneness to recollect things as the party calling them would have them recollect them, aside from the temptation to actual perjury." Trans Web LLC v. See, e.g.: At all times during the Confidentiality-Obligation Period, the Receiving Party must not disclose, use, or copy Confidential Information, in whole or in part, except as expressly provided in the Agreement. A receiving party likely would not want to take on the higher burden of entering into a fiduciary relationship with the disclosing party.
They want to allocate responsibily for arranging for shipping the widgets; insurance; export clearances; and customs. to ensure that any use, disclosure, or copying of Confidential Information, by or on behalf of the Receiving Party or any party receiving Confidential Information from the Receiving Party complies with applicable law, including for example any applicable law concerning (i) privacy or (ii) export controls. (Opinions seem to vary as to whether the term fiduciary relationship and confidential relationship are synonyms; the answer might depend on the jurisdiction. Day, Difference Between Fiduciary Relationships and Confidential Relationships (John Day Legal.com) (citing Tennessee cases).
It can then decide if further investigations need to be carried out or can take action to protect the public from the risks identified, such as updating the information provided for healthcare professionals and patients.
The Agency has published an explanatory note to module VII of the guideline on good pharmacovigilance practices (GVP) providing additional clarification on the content of PSURs.
All MAHs should consult the explanatory note when preparing PSURs.
Currently there are: In cases where there is a formal common name (e.g.
birds), or when common names are well-known and reasonably unique (e.g.